3816
T. Inoue et al. / Tetrahedron: Asymmetry 11 (2000) 3807–3818
The enantiomer (+)-8 was obtained from the mother liquor, and purified with the similar
manner as for (−)-8 using (+)-PA. (+)-8 (2.0 g, 12 mmol, 17%, >99% ee); mp 58.9–59.9°C, [h]D23
+140 (c 1.60, CHCl3) {lit.,20 [h]D +52.8 (c 12.5, EtOH), ee unknown}.
4.6. (−)-(S)-2,2,4-Trimethyl-3-cyclohexene-1-methanol (−)-3
To a suspension of LiAlH4 (350 mg, 9.1 mmol) in dry ether (30 ml) was added dropwise (−)-9
(2.2 g, 12 mmol) in dry ether (12 ml) at 0°C. The resulting mixture was stirred under N2 at room
temperature for 20 min and quenched with EtOH, water and 1N HCl. The mixture was
extracted with ether (50 ml×3), washed with brine, dried over MgSO4, filtered and concentrated
in vacuo. Purification by silica gel column chromatography (hexane:ethyl acetate=2/1) afforded
(−)-3 (1.90 g (12 mmol, quant.) as a colorless oil, [h]2D7 −45 (c 1.2, CHCl3) {lit.,11 [h]D25 −37.5 (c
1.18, CHCl3)}. The spectral data were identical with those reported.11
For (+)-3, [h]2D4 +46 (c 1.6, CHCl3).
4.7. Methyl (1S,2R,5S)-(9,9-dimethyl-8-methylene-3-oxabicyclo[3.3.1]non-6-en-2-yl)acetate:
(+)-16
To a solution of (+)-11 (394 mg, 1.65 mmol) in CHCl3 (20 ml) was added N-bromosuccin-
imide (619 mg, 3.48 mmol) and stirred at room temperature for 12 h. To the mixture was added
additional N-bromosuccinimide (350 mg, 1.97 mmol) and stirred at room temperature for 5 h.
The resulting mixture was poured into water and extracted with ether (50 ml×3). The organic
layer was washed with brine and dried over MgSO4. Then to this was added a small amount of
cyclohexene to remove bromine. The resulting suspension was then filtered and concentrated in
vacuo to give 15. To a solution of this crude dibromide 15 in 1,2-dimethoxyethane (DME, 50
ml) was added zinc powder (7.9 g, 12 mmol) and the mixture was refluxed for 2 h. After being
cooled to room temperature, the suspension was filtered through a Celite pad, and the remaining
solid was washed with ether and water. The filtrate was extracted with ether (50 ml×3). The
organic layer was washed with brine, dried over MgSO4 and concentrated in vacuo. Purification
by silica gel column chromatography (hexane:ethyl acetate=20/1–10/1) and preparative TLC
(hexane:ethyl acetate=5/1) afforded (+)-16 [305 mg, 1.29 mmol, 78% from (+)-11] as a colorless
oil; [h]2D3 +94 (c 1.5, CHCl3). IR (film) wmax: 3070, 3020, 2880, 1730, 1630, 1590, 1170, 1090, 1000,
1
890 cm−1. H NMR (300 MHz) l: 0.95 (s, 3H), 1.26 (s, 3H), 1.8–1.9 (2H), 2.31 (dd, 1H, J=5.4,
15.8 Hz), 2.46 (dd, 1H, J=8.0, 15.9 Hz), 3.40 (dd, 1H, J=1.4, 11.5 Hz), 3.68 (s, 3H), 4.07 (dd,
1H, J=1.8, 11.4 Hz), 4.39 (ddd, 1H, J=2.0, 5.6, 7.7 Hz), 4.69 (s, 1H), 5.09 (d, 1H, J=1.9 Hz),
5.74 (dd, 1H, J=6.7, 9.6 Hz), 6.34 (d, 1H, J=9.6 Hz). 13C NMR (125 MHz) l: 24.2, 28.4, 32.6,
39.2, 41.5, 50.7, 51.6, 64.6, 70.6, 115.6, 129.3, 131.7, 142.6, 172.2. HREIMS m/z (M+): calcd for
C14H20O3: 236.1412; found: 236.1414.
4.8. Methyl (1S,2R,5S)-(9,9-dimethyl-8-methylene-3-oxabicyclo[3.3.1]non-2-yl)acetate: (+)-17
A suspension of (+)-16 (248 mg, 1.05 mmol) and PtO2·(H2O)1–3 (0.04 g) in MeOH (20 ml) was
stirred under H2 at 27°C until 36 ml of H2 (1.5 mmol) was absorbed. The resulting suspension
was filtered through a Celite pad and the filtrate was concentrated in vacuo. Purification by
silica gel column chromatography (hexane:ethyl acetate=20/1) and preparative TLC (hex-
ane:ethyl acetate=5/1) afforded (+)-17 {78 mg, 0.33 mmol, 31%; [h]2D4 +62 (c 1.6, CHCl3)} and